|
End-of-day quote
Korea S.E.
2026-09-10
|
5-day change | 1st Jan Change | ||
| 53,100.00 KRW | -1.30% |
|
-5.68% | -55.75% |
| 08-22 | Orum Therapeutics Receives FDA Clearance Of IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate | CI |
| 07-15 | Alert wrongly tagged to Orum Therapeutics withdrawn | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.30% | -5.68% | -14.22% | -15.04% | -55.75% | +71.01% | - | - | - | 872M | |
| -0.25% | -0.96% | -0.21% | +65.28% | +70.45% | +45.25% | +102.76% | +9.75% | - | 68.52B | |
| -1.09% | -6.20% | +11.58% | +12.16% | +19.39% | +30.50% | +74.05% | +206.74% | +5,855.46% | 62.88B | |
| -1.44% | +0.16% | -5.84% | +38.09% | -27.10% | -13.05% | +378.79% | +367.33% | +815.44% | 28.13B | |
| -2.74% | -3.53% | +3.58% | +58.65% | +51.08% | +26.13% | +13.50% | -60.35% | - | 25.56B | |
| -2.16% | -6.58% | +3.57% | +11.56% | +0.96% | -4.84% | -18.52% | -72.48% | - | 24.65B | |
| -2.39% | -5.19% | +4.57% | +29.54% | +2.76% | +17.75% | -19.64% | -25.15% | +111.36% | 19.81B | |
| -1.86% | +1.15% | +6.45% | +47.90% | +211.54% | +205.44% | +353.89% | +1,664.30% | +812.88% | 17.69B | |
| -1.37% | -3.77% | -12.07% | +22.46% | +20.96% | -9.38% | +528.34% | - | - | 14.66B | |
| -1.40% | -2.49% | +8.87% | +9.66% | +31.55% | +52.94% | +162.21% | +188.88% | +365.00% | 14.45B | |
| -3.88% | -1.49% | +13.48% | +29.31% | -3.52% | -4.15% | +935.28% | +159.62% | +172.24% | 13.99B | |
| -4.63% | -4.33% | +0.73% | +10.14% | -10.86% | +20.69% | +180.61% | +547.90% | +4,676.27% | 12.63B | |
| +0.41% | -3.87% | -5.88% | +17.55% | +25.23% | +187.78% | +184.34% | +29.93% | +1,051.52% | 11.67B | |
| -1.53% | +6.61% | -6.40% | +4.64% | -17.17% | -33.19% | +170.91% | +118.95% | - | 11.16B | |
| -0.40% | -0.18% | -4.74% | +10.06% | +16.18% | +41.96% | +112.55% | +150.07% | +700.65% | 10.3B | |
| -1.43% | -3.84% | +0.91% | +29.50% | +27.48% | +83.81% | +12.21% | +124.85% | - | 8.86B | |
| -4.40% | -6.41% | +2.34% | +9.81% | +287.12% | +198.25% | +397.73% | -22.50% | - | 8.54B | |
| -3.69% | -6.42% | -13.74% | +7.44% | +3.33% | -28.74% | +123.42% | -29.81% | - | 8.26B | |
| +1.38% | +1.31% | -16.08% | +17.73% | +169.81% | +446.29% | +529.11% | -48.08% | -52.54% | 7.66B | |
| -5.49% | +1.65% | +3.98% | +27.29% | +8.72% | +162.43% | +464.83% | - | - | 7.38B | |
| Average | -1.98% | +1.01% | -0.96% | +22.19% | +41.61% | +74.84% | +246.65% | +194.70% | +1,450.83% | 18.88B | |
| Weighted average by Cap. | -1.61% | +0.09% | +1.86% | +30.78% | +40.51% | +50.70% | +187.89% | +183.27% | +2,477.30% |
- Stock Market
- Stocks
- A475830 Stock
- Sector Orum Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
